{"schema_version":"secwatch.filing_event.v1","accession":"0001178913-26-004122","form_type":"8-K","ticker":"SLXN","cik":"0002022416","company_name":"Silexion Therapeutics Corp","filed_at":"2026-08-13T20:02:40+00:00","discovered_at":"2026-08-13T20:04:00.065226+00:00","generated_at":"2026-08-13T20:04:14.822679+00:00","sec_items":["1.01","8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Silexion closes $2.5M public offering; converts $750K debt to equity","bullets":["Offered 2,028,619 shares, 1,817,542 pre-funded warrants, 3,846,161 Series E warrants at $0.65/unit; gross proceeds ~$2.5M.","Net proceeds ~$2.1M; intended for SIL204 clinical trial and general corporate purposes.","Converted $750,001 of sponsor note into 1,153,848 ordinary shares at $0.65/share; note balance now $206,462.","Issued 823,770 shares from pre-funded warrant exercises; adjusted shareholders' equity ~$3.2M as of June 30, 2026.","H.C. Wainwright sole placement agent; fees 7% cash, 1% management, plus 269,231 placement agent warrants."],"urls":{"canonical":"https://secwatch.observer/filing/0001178913-26-004122","json":"https://secwatch.observer/filing/0001178913-26-004122.json","markdown":"https://secwatch.observer/filing/0001178913-26-004122.md","text":"https://secwatch.observer/filing/0001178913-26-004122.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/2022416/000117891326004122/0001178913-26-004122-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/2022416/000117891326004122/zk2635949.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-08-13T20:04:14.822679+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}